Mirja Amadea Minger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mirja Amadea Minger has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Sabrina Kohl Schwartz
Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland
2 shared publications - Michael von Wolff
Division of Gynecological Endocrinology and Reproductive Medicine, Women’s University Hospital, Inselspital Bern, University of Bern, 3010 Bern, Switzerland
2 shared publications - Vera Ruth Mitter
University of Oslo, Oslo, Norway
2 shared publications Alexandra Sabrina Kohl Schwartz
1 shared publicationAnna Spaeth
Swiss Tropical and Public Health Institute Basel Switzerland
1 shared publication- Costanzo Limoni
University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland
1 shared publication
Latest Publications
- Open Access
- 7 November 2023
- Published by Springer Nature in Research Square
Childhood growth of singletons conceived following assisted reproductive technology - does gonadotropin stimulation matter?
Purpose: To investigate whether gonadotropin stimulation influences growth or weight gain of children conceived following assisted reproductive technology.Methods: We conducted a single-center, prospective cohort study (2010–2017) including children (n = 139) born after natural-cycle intracytoplasmic sperm injection (NC-ICSI) or conventional gonadotropin stimulated intracytoplasmic sperm injection (c-ICSI) treatment. Growth parameters up to 24 months were collected. Standard deviation scores based on growth references were calculated.Results: The median birth weight in NC-ICSI children was 3.4kg (0.1 standard deviation score (SDS)) compared to 3.3kg (-0.3 SDS) in c-ICSI children (p = 0.61). Median length at birth was 50cm in both groups (NC-ICS (-0.5 SDS), c-ICSI children (-0.8 SDS), p = 0.48). At age 24 months, median weight in NC-ICSI children was 12.2kg (0.3 SDS) versus 12.2kg (0.2 SDS) in c-ICSI children (p = 0.82) and median length 87.5cm (0.1 SDS) versus 88.0cm (0.4 SDS) (p = 0.43).Conclusion: We found no difference in growth between children conceived after stimulated and unstimulated ICSI. Growth parameters of both treatment groups did not differ from Swiss national growth references. One of the main limitations of our study was the small sample size (N = 139) and the high drop-out rate of 49% (68/139).
- 7 November 2023
- Published by Springer Nature in Research Square
Open AccessChildhood growth of singletons conceived following assisted reproductive technology - does gonadotropin stimulation matter?
Purpose: To investigate whether gonadotropin stimulation influences growth or weight gain of children conceived following assisted reproductive technology.Methods: We conducted a single-center, prospective cohort study (2010–2017) including children (n = 139) born after natural-cycle intracytoplasmic sperm injection (NC-ICSI) or conventional gonadotropin stimulated intracytoplasmic sperm injection (c-ICSI) treatment. Growth parameters up to 24 months were collected. Standard deviation scores based on growth references were calculated.Results: The median birth weight in NC-ICSI children was 3.4kg (0.1 standard deviation score (SDS)) compared to 3.3kg (-0.3 SDS) in c-ICSI children (p = 0.61). Median length at birth was 50cm in both groups (NC-ICS (-0.5 SDS), c-ICSI children (-0.8 SDS), p = 0.48). At age 24 months, median weight in NC-ICSI children was 12.2kg (0.3 SDS) versus 12.2kg (0.2 SDS) in c-ICSI children (p = 0.82) and median length 87.5cm (0.1 SDS) versus 88.0cm (0.4 SDS) (p = 0.43).Conclusion: We found no difference in growth between children conceived after stimulated and unstimulated ICSI. Growth parameters of both treatment groups did not differ from Swiss national growth references. One of the main limitations of our study was the small sample size (N = 139) and the high drop-out rate of 49% (68/139).
- Open Access
- 31 August 2020
- Published by Wiley in Acta Paediatrica
- Vol. 110 (4) , 1171-1180
Breastfeeding following in vitro fertilisation in Switzerland—Does mode of conception affect breastfeeding behaviour?
Aim: Breastfeeding has numerous advantages. Our aim was to investigate whether breastfeeding initiation and duration in women with pregnancies conceived through in vitro fertilisation differ from spontaneously conceived pregnancies.Methods: This is a comparative cross‐sectional study about breastfeeding behaviour performed at the Bern University Hospital including mothers of singletons conceived by in vitro fertilisation (n = 198) with or without gonadotropin stimulation between 2010 and 2016 (in vitro fertilisation group). They were compared to a population‐based control group (n = 1421) of a randomly selected sample of mothers in Switzerland who delivered in 2014.Results: A total of 1619 women were included in this analysis. Breastfeeding initiation rates were high, similar between the in vitro fertilisation group (93.4%) and the control group (94.8%). No increased risk of stopping breastfeeding earlier after in vitro fertilisation treatment compared to the control group could be found over the observational period of 12 months (HR = 1.00, 95% CI 0.83‐1.20, P = .984). There was no difference in breastfeeding initiation or duration after gonadotropin‐stimulated vs unstimulated in vitro fertilisation.Conclusion: In Switzerland, in vitro fertilisation treatments were not associated with earlier breastfeeding cessation. This result is reassuring for mothers undergoing in vitro fertilisation.
- 31 August 2020
- Published by Wiley in Acta Paediatrica
- Vol. 110 (4) , 1171-1180
Open AccessBreastfeeding following in vitro fertilisation in Switzerland—Does mode of conception affect breastfeeding behaviour?
Aim: Breastfeeding has numerous advantages. Our aim was to investigate whether breastfeeding initiation and duration in women with pregnancies conceived through in vitro fertilisation differ from spontaneously conceived pregnancies.Methods: This is a comparative cross‐sectional study about breastfeeding behaviour performed at the Bern University Hospital including mothers of singletons conceived by in vitro fertilisation (n = 198) with or without gonadotropin stimulation between 2010 and 2016 (in vitro fertilisation group). They were compared to a population‐based control group (n = 1421) of a randomly selected sample of mothers in Switzerland who delivered in 2014.Results: A total of 1619 women were included in this analysis. Breastfeeding initiation rates were high, similar between the in vitro fertilisation group (93.4%) and the control group (94.8%). No increased risk of stopping breastfeeding earlier after in vitro fertilisation treatment compared to the control group could be found over the observational period of 12 months (HR = 1.00, 95% CI 0.83‐1.20, P = .984). There was no difference in breastfeeding initiation or duration after gonadotropin‐stimulated vs unstimulated in vitro fertilisation.Conclusion: In Switzerland, in vitro fertilisation treatments were not associated with earlier breastfeeding cessation. This result is reassuring for mothers undergoing in vitro fertilisation.
- Open Access
- 23 July 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (12) , 1575-1584
The greater incidence of small‐for‐gestational‐age newborns after gonadotropin‐stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day
Introduction: Reproductive scientists have postulated various risk factors for lower birthweight following conventional gonadotropin‐stimulated in vitro fertilization compared with spontaneously conceived children: parental factors (age, health, duration of subfertility and smoking habits); ovarian stimulation; laboratory procedures; the number of oocytes retrieved and the number of embryos transferred. Our aim was to investigate the impact of gonadotropin stimulation and serum estradiol level on the risk of a newborn being small‐for‐gestational‐age.Material and methods: We conducted a cohort study (2010‐2016) of singletons (n = 155) born either after conventional gonadotropin‐stimulated in vitro fertilization (using ≥150 IU/d human gonadotropin for stimulation) or after natural cycle in vitro fertilization without any stimulation. We analyzed perinatal outcomes using birthweight percentiles, adjusted for gestational age and sex.Results: The proportion of small‐for‐gestational‐age was 11.8% following conventional gonadotropin‐stimulated in vitro fertilization and 2.9% after natural cycle in vitro fertilization (P = 0.058). The odds of small‐for‐gestational‐age were significantly higher with supraphysiological estradiol levels in maternal serum on ovulation trigger day (unadjusted odds ratio 4.58; 95% confidence interval 1.35‐15.55; P = 0.015). It remained significant after adjusting for maternal height, age and body mass index (adjusted odds ratio 3.83; 95% confidence interval 1.06‐13.82; P = 0.041).Conclusions: We found an associated risk of children being born small‐for‐gestational‐age after conventional gonadotropin‐stimulated in vitro fertilization compared with natural cycle in vitro fertilization. This higher risk is significantly associated with supraphysiological estradiol levels. We propose a reduction in the dosage of gonadotropin to minimize the risk of small‐for‐gestational‐age and future health consequences.
- 23 July 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (12) , 1575-1584
Open AccessThe greater incidence of small‐for‐gestational‐age newborns after gonadotropin‐stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day
Introduction: Reproductive scientists have postulated various risk factors for lower birthweight following conventional gonadotropin‐stimulated in vitro fertilization compared with spontaneously conceived children: parental factors (age, health, duration of subfertility and smoking habits); ovarian stimulation; laboratory procedures; the number of oocytes retrieved and the number of embryos transferred. Our aim was to investigate the impact of gonadotropin stimulation and serum estradiol level on the risk of a newborn being small‐for‐gestational‐age.Material and methods: We conducted a cohort study (2010‐2016) of singletons (n = 155) born either after conventional gonadotropin‐stimulated in vitro fertilization (using ≥150 IU/d human gonadotropin for stimulation) or after natural cycle in vitro fertilization without any stimulation. We analyzed perinatal outcomes using birthweight percentiles, adjusted for gestational age and sex.Results: The proportion of small‐for‐gestational‐age was 11.8% following conventional gonadotropin‐stimulated in vitro fertilization and 2.9% after natural cycle in vitro fertilization (P = 0.058). The odds of small‐for‐gestational‐age were significantly higher with supraphysiological estradiol levels in maternal serum on ovulation trigger day (unadjusted odds ratio 4.58; 95% confidence interval 1.35‐15.55; P = 0.015). It remained significant after adjusting for maternal height, age and body mass index (adjusted odds ratio 3.83; 95% confidence interval 1.06‐13.82; P = 0.041).Conclusions: We found an associated risk of children being born small‐for‐gestational‐age after conventional gonadotropin‐stimulated in vitro fertilization compared with natural cycle in vitro fertilization. This higher risk is significantly associated with supraphysiological estradiol levels. We propose a reduction in the dosage of gonadotropin to minimize the risk of small‐for‐gestational‐age and future health consequences.